Boramino acid as a marker for amino acid transporters

Science Advances

Volumn 1, Issue 8, 2015, Pages

  Liu, Zhibo ^a   Chen, Haojun ^a,b   Chen, Kai ^c   Shao, Yihan ^d   Kiesewetter, Dale O ^a   Niu, Gang ^a   Chen, Xiaoyuan ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CARBOXYLATION; PROBES;

AMINO ACID TRANSPORTER; ANIMAL STUDIES; CELL UPTAKE; CELLULAR UPTAKE; IMAGING PROBE; IN-VIVO; MENTAL DISEASE;

ASCORBIC ACID;

EID: 84977862471     PISSN: None     EISSN: 23752548     Source Type: Journal    
DOI: 10.1126/sciadv.1500694     Document Type: Article

References (34)

1. B. Liu, H. Du, R. Rutkowski, A. Gartner, X. Wang, LAAT-1 is the lysosomal lysine/arginine transporter that maintains amino acid homeostasis. Science 337, 351-354 (2012).
2. E. G. Geier, A. Schlessinger, H. Fan, J. E. Gable, J. J. Irwin, A. Sali, K. M. Giacomini, Structurebased ligand discovery for the large-neutral amino acid transporter 1, LAT-1. Proc. Natl. Acad. Sci. U.S.A. 110, 5480-5485 (2013).
3. M. V. Yelshanskaya, M. Li, A. I. Sobolevsky, Structure of an agonist-bound ionotropic glutamate receptor. Science 345, 1070-1074 (2014).
4. S. J. Shabel, C. D. Proulx, J. Piriz, R. Malinow, GABA/glutamate co-release controls habenula output and is modified by antidepressant treatment. Science 345, 1494-1498 (2014).
5. S. A. Lipton, P. A. Rosenberg, Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613-622 (1994).
6. Y. D. Bhutia, E. Babu, S. Ramachandran, V. Ganapathy, Amino acid transporters in cancer and their relevance to "glutamine addiction": Novel targets for the design of a new class of anticancer drugs. Cancer Res. 75, 1782-1788 (2015).
7. B. C. Fuchs, B. P. Bode, Amino acid transporters ASCT2 and LAT1 in cancer: Partners in crime? Semin. Cancer Biol. 15, 254-266 (2005).
8. D. Hanahan, R. A. Weinberg, Hallmarks of cancer: The next generation. Cell 144, 646-674 (2011).
9. A. Detta, G. S. Cruickshank, L-Amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors. Cancer Res. 69, 2126-2132 (2009).
10. E. S. Garnett, G. Firnau, C. Nahmias, Dopamine visualized in the basal ganglia of living man. Nature 305, 137-138 (1983).
11. D. M. Schuster, J. R. Votaw, P. T. Nieh, W. Yu, J. A. Nye, V. Master, F. D. Bowman, M.M. Issa, M.M. Goodman, Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane- 1-carboxylic acid with PET/CT in prostate carcinoma. J. Nucl. Med. 48, 56-63 (2007).
12. S. Venneti, M. P. Dunphy, H. Zhang, K. L. Pitter, P. Zanzonico, C. Campos, S. D. Carlin, R. G. La, S. Lyashchenko, K. Ploessl, D. Rohle, A. M. Omuro, J. R. Cross, C. W. Brennan, W. A. Weber, E. C. Holland, I. K. Mellinghoff, H. F. Kung, J. S. Lewis, C. B. Thompson, Glutamine-based pet imaging facilitates enhanced metabolic evaluation of gliomas in vivo. Sci. Transl. Med. 7, 274ra217 (2015).
13. J. McConathy, M. Goodman, Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography. Cancer Metastasis Rev. 27, 555-573 (2008).
14. T. M. Shoup, M. M. Goodman, Synthesis of [F-18]-1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC): A pet tracer for tumor delineation. J. Labelled Compd. Radiopharm. 42, 215-225 (1999).
15. S. Oka, R. Hattori, F. Kurosaki, M. Toyama, L. A. Williams, W. Yu, J. R. Votaw, Y. Yoshida, M. M. Goodman, O. Ito, A preliminary study of anti-1-amino-3-18F-fluorocyclobutyl-1-carboxylic acid for the detection of prostate cancer. J. Nucl. Med. 48, 46-55 (2007).
16. P. L. Jager, W. Vaalburg, J. Pruim, E. G. de Vries, K. J. Langen, D. A. Piers, Radiolabeled amino acids: Basic aspects and clinical applications in oncology. J. Nucl. Med. 42, 432-445 (2001).
17. K. Smolarz, B. J. Krause, F. P. Graner, F. M. Wagner, C. Hultsch, C. Bacher-Stier, R. B. Sparks, S. Ramsay, L. M. Fels, L. M. Dinkelborg, M. Schwaiger, (S)-4-(3-18F-Fluoropropyl)-L-glutamic acid: An 18F-labeled tumor-specific probe for PET/CT imaging-Dosimetry. J. Nucl. Med. 54, 861-866 (2013).
18. M. Huiban, M. Tredwell, S. Mizuta, Z. Wan, X. Zhang, T. L. Collier, V. Gouverneur, J. Passchier, A broadly applicable [18F]trifluoromethylation of aryl and heteroaryl iodides for pet imaging. Nat. Chem. 5, 941-944 (2013).
19. W. Qu, Z. Zha, K. Ploessl, B. P. Lieberman, L. Zhu, D. R. Wise, C. B. Thompson, H. F. Kung, Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors. J. Am. Chem. Soc. 133, 1122-1133 (2011).
20. Z. Liu, M. Pourghiasian, M. A. Radtke, J. Lau, J. Pan, G. M. Dias, D. Yapp, K. S. Lin, F. Bénard, D. M. Perrin, An organotrifluoroborate for broadly applicable one-step 18F-labeling. Angew. Chem. Int. Ed. 53, 11876-11880 (2014).
21. Z. Liu, D. Chao, Y. Li, R. Ting, J. Oh, D. M. Perrin, From minutes to years: Predicting organotrifluoroborate solvolysis rates. Chemistry 21, 3924-3928 (2015).
22. M. A. Beenen, C. An, J. A. Ellman, Asymmetric copper-catalyzed synthesis of a-amino boronate esters from N-tert-butanesulfinyl aldimines. J. Am. Chem. Soc. 130, 6910-6911 (2008).
23. R. Smoum, A. Rubinstein, V. M. Dembitsky, M. Srebnik, Boron containing compounds as protease inhibitors. Chem. Rev. 112, 4156-4220 (2012).
24. O. Yanagida, Y. Kanai, A. Chairoungdua, D. K. Kim, H. Segawa, T. Nii, S. H. Cha, H. Matsuo, J. Fukushima, Y. Fukasawa, Y. Tani, Y. Taketani, H. Uchino, J. Y. Kim, J. Inatomi, I. Okayasu, K. Miyamoto, E. Takeda, T. Goya, H. Endou, Human L-type amino acid transporter 1 (LAT1): Characterization of function and expression in tumor cell lines. Biochim. Biophys. Acta 1514, 291-302 (2001).
25. G. A. Kimmich, J. Randles, J. Wilson, Na(+)-coupled alanine transport in LLC-PK1 cells. Am. J. Physiol. 267, C1119-C1129 (1994).
26. K. J. Langen, A. R. Börner, V. Müller-Mattheis, K. Hamacher, H. Herzog, R. Ackermann, H. H. Coenen, Uptake of cis-4-[18F]fluoro-l-proline in urologic tumors. J. Nucl. Med. 42, 752-754 (2001).
27. M. Biasini, S. Bienert, A. Waterhouse, K. Arnold, G. Studer, T. Schmidt, F. Kiefer, T. G. Cassarino, M. Bertoni, L. Bordoli, T. Schwede, SWISS-MODEL: Modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 42, W252-W258 (2014).
28. X. Gao, L. Zhou, X. Jiao, F. Lu, C. Yan, X. Zeng, J. Wang, Y. Shi, Mechanism of substrate recognition and transport by an amino acid antiporter. Nature 463, 828-832 (2010).
29. K. Vanommeslaeghe, E. Hatcher, C. Acharya, S. Kundu, S. Zhong, J. Shim, E. Darian, O. Guvench, P. Lopes, I. Vorobyov, A. D. Mackerell Jr., CHARMM general force field: A force field for druglike molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 31, 671-690 (2010).
30. J. R. Perilla, B. C. Goh, C. K. Cassidy, B. Liu, R. C. Bernardi, T. Rudack, H. Yu, Z. Wu, K. Schulten, Molecular dynamics simulations of large macromolecular complexes. Curr. Opin. Struct. Biol. 31, 64-74 (2015).
31. R. A. Laskowski, M. W. MacArthur, D. S. Moss, J. M. Thornton, PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283-291 (1993).
32. G. M. Morris, R. Huey, W. Lindstrom, M. F. Sanner, R. K. Belew, D. S. Goodsell, A. J. Olson, AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785-2791 (2009).
33. K. Chen, A. F. Aowad, S. J. Adelstein, A. I. Kassis, Molecular-docking-guided design, synthesis, and biologic evaluation of radioiodinated quinazolinone prodrugs. J. Med. Chem. 50, 663-673 (2007).
34. X. Wu, Z. Liu, S. Huang, W. Wang, Molecular dynamics simulation of room-temperature ionic liquid mixture of [bmim][BF4] and acetonitrile by a refined force field. Phys. Chem. Chem. Phys. 7, 2771-2779 (2005).